INVESTMENTS THAT MATTER

Agent Capital is a healthcare venture capital firm focused on investing in novel, differentiated therapeutics and treatments that address unmet patient needs.

Across all stages of development, we align ourselves with scientists, entrepreneurs and other investors to develop the next generation of healthcare innovations that will have a positive impact on patients’ lives.

OUR PROVEN STRATEGY

At Agent Capital, we proactively guide biotech companies to milestones and exits.

With a balanced investment approach and a deep understanding of biopharma’s pipeline pressures, we are committed to making investments that move healthcare forward – no matter the stage or investment type.

TYPICALLY, OUR KEY INVESTMENT AREAS OF FOCUS INCLUDE:

Rare Diseases
Oncology
Neurology
Immunology
Learn More

Featured Portfolio Company

Aptinyx

Carisma Therapeutics

Orbus Therapeutics

Orchard Therapeutics

Palvella Therapeutics

Pliant Therapeutics

Precision Biosciences

Skyhawk Therapeutics

Verge Genomics

View Full Portfolio

Featured News

News | November 5, 2018

Orchard Therapeutics Announces Closing of $225 Million Initial Public Offering

Read More

Press Release | July 16, 2018

Pliant Therapeutics Raises $62 Million in Series B Financing

Read More

Press Release | July 16, 2018

Verge Genomics Announces $32 Million Series A

Read More

View All